78.49
price down icon1.89%   -1.51
pre-market  Pre-market:  79.95   1.46   +1.86%
loading
Edwards Lifesciences Corp stock is traded at $78.49, with a volume of 6.02M. It is down -1.89% in the last 24 hours and up +0.36% over the past month. Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
See More
Previous Close:
$80.00
Open:
$80.45
24h Volume:
6.02M
Relative Volume:
1.35
Market Cap:
$46.04B
Revenue:
$5.69B
Net Income/Loss:
$4.15B
P/E Ratio:
11.29
EPS:
6.95
Net Cash Flow:
$623.10M
1W Performance:
+2.52%
1M Performance:
+0.36%
6M Performance:
+8.17%
1Y Performance:
+25.85%
1-Day Range:
Value
$78.37
$80.73
1-Week Range:
Value
$75.39
$83.00
52-Week Range:
Value
$59.41
$83.00

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
Name
Edwards Lifesciences Corp
Name
Phone
(949) 250-2500
Name
Address
ONE EDWARDS WAY, IRVINE, CA
Name
Employee
15,800
Name
Twitter
@edwardslifesci
Name
Next Earnings Date
2025-02-11
Name
Latest SEC Filings
Name
EW's Discussions on Twitter

Compare EW with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
78.49 46.93B 5.69B 4.15B 623.10M 6.95
Medical Devices icon
ABT
Abbott Laboratories
126.35 220.16B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
105.84 157.03B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
400.69 154.21B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.97 119.08B 33.54B 4.66B 5.19B 3.62

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-24-25 Upgrade Piper Sandler Neutral → Overweight
Jan-30-25 Upgrade Stifel Hold → Buy
Jan-16-25 Downgrade Wolfe Research Peer Perform → Underperform
Dec-16-24 Upgrade BofA Securities Neutral → Buy
Oct-11-24 Resumed Morgan Stanley Equal-Weight
Sep-18-24 Downgrade Jefferies Buy → Hold
Jul-31-24 Upgrade Daiwa Securities Neutral → Outperform
Jul-29-24 Upgrade Wolfe Research Underperform → Peer Perform
Jul-25-24 Downgrade BofA Securities Buy → Neutral
Jul-25-24 Downgrade JP Morgan Overweight → Neutral
Jul-25-24 Downgrade Robert W. Baird Outperform → Neutral
Jul-25-24 Downgrade TD Cowen Buy → Hold
Jul-25-24 Downgrade Truist Buy → Hold
May-30-24 Initiated Goldman Buy
May-22-24 Upgrade Citigroup Neutral → Buy
May-14-24 Upgrade Deutsche Bank Hold → Buy
Mar-07-24 Upgrade BofA Securities Neutral → Buy
Feb-02-24 Upgrade Wells Fargo Equal Weight → Overweight
Jan-04-24 Downgrade Evercore ISI Outperform → In-line
Dec-11-23 Downgrade Citigroup Buy → Neutral
Nov-28-23 Downgrade Wolfe Research Peer Perform → Underperform
Sep-26-23 Upgrade Oppenheimer Perform → Outperform
Jul-19-23 Initiated Robert W. Baird Outperform
May-30-23 Resumed Morgan Stanley Overweight
Mar-29-23 Initiated UBS Neutral
Mar-08-23 Downgrade Wells Fargo Overweight → Equal Weight
Feb-06-23 Downgrade Raymond James Outperform → Mkt Perform
Jan-31-23 Downgrade Bernstein Outperform → Underperform
Jan-30-23 Downgrade Piper Sandler Overweight → Neutral
Dec-06-22 Downgrade Stifel Buy → Hold
Oct-28-22 Downgrade Oppenheimer Outperform → Perform
Oct-26-22 Initiated Mizuho Buy
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-29-22 Downgrade Canaccord Genuity Buy → Hold
Apr-13-22 Initiated Truist Buy
Apr-06-22 Initiated Wolfe Research Outperform
Mar-16-22 Upgrade Bernstein Mkt Perform → Outperform
Mar-02-22 Resumed BofA Securities Neutral
Feb-02-22 Upgrade UBS Neutral → Buy
Jan-27-22 Reiterated Citigroup Buy
Jan-27-22 Reiterated Evercore ISI Outperform
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated Stifel Buy
Jan-27-22 Reiterated UBS Neutral
Dec-17-21 Upgrade JP Morgan Neutral → Overweight
Dec-15-21 Upgrade Citigroup Neutral → Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Dec-06-21 Upgrade Wells Fargo Equal Weight → Overweight
Jul-30-21 Reiterated Canaccord Genuity Buy
Jul-30-21 Reiterated Deutsche Bank Hold
Jul-30-21 Reiterated Jefferies Buy
Jul-30-21 Reiterated Morgan Stanley Overweight
Jul-30-21 Reiterated Oppenheimer Outperform
Jul-30-21 Reiterated Stifel Buy
Jul-30-21 Reiterated UBS Neutral
Jul-30-21 Reiterated Wells Fargo Equal Weight
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Apr-05-21 Upgrade Evercore ISI In-line → Outperform
Dec-16-20 Downgrade Citigroup Buy → Neutral
Dec-11-20 Reiterated Canaccord Genuity Buy
Sep-11-20 Initiated Wolfe Research Underperform
Apr-28-20 Downgrade Wells Fargo Overweight → Equal Weight
Apr-17-20 Upgrade SVB Leerink Mkt Perform → Outperform
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-10-20 Initiated Oppenheimer Outperform
Jan-02-20 Downgrade Evercore ISI Outperform → In-line
Oct-24-19 Reiterated Canaccord Genuity Buy
Sep-23-19 Initiated Piper Jaffray Overweight
Jul-24-19 Reiterated BofA/Merrill Buy
Mar-18-19 Reiterated Canaccord Genuity Buy
Jan-18-19 Upgrade BofA/Merrill Neutral → Buy
Jan-03-19 Initiated Deutsche Bank Hold
Nov-28-18 Initiated UBS Neutral
Oct-16-18 Initiated Barclays Underweight
Oct-02-18 Downgrade BofA/Merrill Buy → Neutral
Oct-02-18 Downgrade Guggenheim Buy → Neutral
View All

Edwards Lifesciences Corp Stock (EW) Latest News

pulisher
Jul 28, 2025

Edwards Lifesciences Insider Makes a Major Stock Move! - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Edwards Lifesciences Reports Strong Growth and Raises Guidance - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Edwards Lifesciences debuts heart valve failure PSA as Rams training camp begins - Medical Marketing and Media

Jul 28, 2025
pulisher
Jul 28, 2025

Edwards Lifesciences stock price target raised to $85 by Bernstein - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Edwards Lifesciences stock price target raised to $85 by UBS on strong TAVR sales - Investing.com

Jul 28, 2025
pulisher
Jul 28, 2025

Edwards Lifesciences’ SWOT analysis: strong TAVR growth boosts stock outlook - Investing.com

Jul 28, 2025
pulisher
Jul 27, 2025

When is Edwards Lifesciences Corporation stock expected to show significant growthExceptional return forecasts - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Edwards Lifesciences Corporation a growth stock or a value stockDiscover breakthrough stocks before the crowd - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How volatile is Edwards Lifesciences Corporation stock compared to the marketFree Stock Selection - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Edwards Lifesciences (EW) Announces Executive Leadership Change - GuruFocus

Jul 27, 2025
pulisher
Jul 27, 2025

Can Edwards Lifesciences Corporation stock recover from recent declineTriple Return With Stability - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

Edwards Lifesciences stock price target raised to $90 by Piper Sandler - Investing.com

Jul 27, 2025
pulisher
Jul 26, 2025

Earnings Preview: What To Expect From Edwards Lifesciences' Report - MSN

Jul 26, 2025
pulisher
Jul 26, 2025

Edwards Lifesciences Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo.co

Jul 26, 2025
pulisher
Jul 26, 2025

Edwards Lifesciences stock price target raised to $84 from $75 at TD Cowen - Investing.com

Jul 26, 2025
pulisher
Jul 26, 2025

Edwards Lifesciences stock price target raised to $89 at RBC on growth outlook - Investing.com

Jul 26, 2025
pulisher
Jul 25, 2025

JPMorgan Adjusts Edwards Lifesciences (EW) Price Target Followin - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Target Price Raised by JP Morgan | EW Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences sales up nearly 12% in Q2 - MassDevice

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corporation Stock Analysis and ForecastPhenomenal returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Q2 EarningsEdwards Lifesciences (NYSE:EW) - Benzinga

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Exec Larry Wood Departs for Procept BioRobotics - Orange County Business Journal

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Target Price Raised by Baird Analyst | - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences’ MITRIS Valve Study: A Key Development for Investors - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences stock reaches 52-week high at 81.86 USD - Investing.com

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results - Benzinga

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Surpasses Earnings and Revenue Expecta - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Q2 2025 Earnings Report - MarketBeat

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Receives Price Target Upgrade from Deutsche Bank | EW Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW) - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences (EW) Receives Price Target Boost from Baird | EW Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

JPMorgan Adjusts Edwards Lifesciences (EW) Price Target Following Strong Q2 Results | EW Stock News - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards loses longtime TAVR leader Larry Wood - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised ... - Yahoo Finance

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised ... By GuruFocus - Investing.com Canada

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Corp (EW) Q2 2025 Earnings Call Highlights: Strong Sales Growth and Raised Guidance - GuruFocus

Jul 25, 2025
pulisher
Jul 25, 2025

Edwards Lifesciences Reports Strong Q2 Growth - TipRanks

Jul 25, 2025
pulisher
Jul 24, 2025

Earnings call transcript: Edwards Lifesciences Q2 2025 beats forecasts, stock dips - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Earnings call transcript: Edwards Lifesciences Q2 2025 beats forecasts, stock dips By Investing.com - Investing.com South Africa

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences (EW) Surges After Earnings Report | EW Stock News - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

After-hours movers: Edwards Lifesciences, Intel, Deckers Brands and more - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Compared to Estimates, Edwards Lifesciences (EW) Q2 Earnings: A Look at Key Metrics - Yahoo Finance

Jul 24, 2025
pulisher
Jul 24, 2025

After-hours movers: Edwards Lifesciences, Intel, Deckers Brands and more By Investing.com - Investing.com Canada

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences Corp Reports Q2 Revenue of $1.53 Billion, E - GuruFocus

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences shares leap 7% on strong Q2 results, sales growth guidance - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences Corp. Reports Retreat In Q2 Income - Nasdaq

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences earnings beat by $0.05, revenue topped estimates - Investing.com

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences Reports Second Quarter Results - Stock Titan

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards recalls certain arterial cannula devices - MassDevice

Jul 24, 2025
pulisher
Jul 24, 2025

Edwards Lifesciences (EW) Awaits Key Earnings Report | EW Stock News - GuruFocus

Jul 24, 2025

Edwards Lifesciences Corp Stock (EW) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.74
price up icon 0.17%
$89.53
price up icon 0.61%
medical_devices PHG
$25.66
price down icon 1.91%
medical_devices STE
$226.53
price down icon 1.71%
$292.27
price up icon 0.71%
Cap:     |  Volume (24h):